Biotech · Private company
Ablynx, a Sanofi company
Track this companyFree. Adds Ablynx, a Sanofi company to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CaplacizumabPhase 3 · Acquired Thrombotic Thrombocytopenic PurpuraClinicalTrials.gov · fetched Nov 12, 2026
- ALX-0061Phase 2 · Lupus Erythematosus, SystemicClinicalTrials.gov · fetched Nov 12, 2026
- ALX-0061Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- MethotrexatePhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- TocilizumabPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic PurpuraPHASE3 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02553317 · fetched Nov 12, 2026
- A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02437890 · fetched Nov 12, 2026
- A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisPHASE2 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02287922 · fetched Nov 12, 2026
- A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisPHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02309359 · fetched Nov 12, 2026
- Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)PHASE2 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT01151423 · fetched Nov 12, 2026